Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
09/2004
09/16/2004US20040180829 Compounds and methods for regulating bacterial growth and pathogenesis
09/15/2004EP1456193A1 PREPARATION OF TRANS-FUSED 3,3a,8,12b-TETRAHYDRO-2 i H /i -DIBENZO 3,4:6,7]CYCLOHEPTA 1,2-b]FURAN DERIVATIVES
09/15/2004EP1456192A1 Deuterated substituted dihydrofuranones and medicaments containing these compounds
09/15/2004EP1456170A1 Aminoacetonitrile derivatives and their use for controlling parasites
09/15/2004EP1237884B1 Process for the preparation of trans-3-alkyloxy-4-hydroxytetrahydrofuran
09/15/2004EP1140887B1 Phase transfer catalyzed method for preparing oxybisphthalic compounds
09/15/2004EP1024896B1 Process for regeneration of carbon-supported, rhenium-containing catalysts
09/15/2004EP0986384A4 Inhibitors of protein isoprenyl transferases
09/15/2004EP0702517B1 Quaternary ammonium and waterproofing/preservative compositions
09/15/2004CN1528756A Technical method for extracting salvianolic acid B from radix salivae miltiorrhizae
09/15/2004CN1528755A Method for synthesizing conjugate vitaminc linoleate
09/15/2004CN1528742A Compound for treating asthma, irritability an a inflammation and its intermediate
09/15/2004CN1166782C Continuous process for preparing optically pure (S)-3,4-dihydroxybutyric acid derivatives
09/15/2004CN1166781C Continous process for preparing optically pure (S)-3-hydroxy-gamma-butyrolactone
09/15/2004CN1166660C Process for preparing N-methyl piperethanamine salt
09/15/2004CN1166659C Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites
09/15/2004CN1166658C 4,5-diaryl-3(i(2H))-furanone derivatives as cyclooxygenase-2 inhibitors
09/15/2004CN1166657C Dihydrofuran heterocyclic compounds and synthesis process thereof
09/15/2004CN1166654C Benzoylguanidine derivatives wit advantageous properties, method for producing them and their use in production of medicaments
09/14/2004US6790997 Oxidation of alcohols in the presence of osmium compounds as catalysts in water or a solvent mixture
09/14/2004US6790973 Reduction of ketone to alcohol using complex catalyst
09/14/2004US6790866 Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient
09/14/2004US6790834 Cytostatic agents
09/14/2004CA2280708C Cetp activity inhibitors
09/14/2004CA2264549C Spirocyclic dopamine receptor subtype ligands
09/14/2004CA2103110C Insecticidal n'-substituted-n,n'-diacylhydrazines
09/10/2004WO2004076436A1 Method for preparing oxydiphthalic anhydrides using bicarbonate as catalyst
09/10/2004WO2004076433A1 Dipeptidyl peptidase inhibitors
09/10/2004WO2004075853A2 Halogenated triptolide derivatives as immunomodulators and anticancer agents
09/10/2004WO2004056727A8 Process of making chalcone derivatives
09/10/2004WO2004050795A3 Antioxidant-functionalized polymers
09/10/2004WO2004050643A3 Non-nucleoside reverse transcriptase inhibitors
09/10/2004WO2004043392B1 Mucin synthesis inhibitors
09/10/2004WO2004041211A3 INHIBITORS OF β-SECRETASE, AND THEIR USE FOR THE PREVENTION OR TREATMENT OF ALZHEIMER’S DISEASE OR MILD COGNITIVE IMPAIRMENT
09/10/2004WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives
09/10/2004WO2004017920B1 Novel biphenyl and biphenyl-like cannabinoids
09/10/2004WO2003079984A3 Substituted tetracycline compounds
09/10/2004CA2515842A1 Halogenated triptolide derivatives as immunomodulators and anticancer agents
09/09/2004US20040176630 Methacrylate compounds with transparency patterns
09/09/2004US20040176462 NPY Y5 antagonist
09/09/2004US20040176461 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents;
09/09/2004US20040176458 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
09/09/2004US20040176445 Propionic acid derivatives
09/09/2004US20040176437 Novel compounds for treatment of cardiac arrhythmia, synthesis, and methods of use
09/09/2004US20040176435 example compound: (3S)-3-(1-Benzothien-7-yloxy)-N-methyl-3-phenyl-1-propanamine oxalate; depression, OCD, anxiety, memory loss, urinary incontinence, conduct disorders, ADHD, obesity, alcoholism, smoking cessation and pain
09/09/2004US20040175342 Process of making and using composition containing oxidation-sensitive hydrophilic active principle and maleic anhydride copolymer
09/08/2004EP1453792A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
09/08/2004EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/08/2004EP1453514A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
09/08/2004EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
09/08/2004EP0927188B1 Novel nucleoside analogs with polycyclic aromatic groups attached, methods of synthesis and uses therefor
09/08/2004CN1527836A Antiviral agents for treatment of flaviviridae infections
09/08/2004CN1527826A Method for the production of phthalic anhydride to a specification
09/08/2004CN1527825A Method for the preparation of escitalopram
09/08/2004CN1527824A Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists
09/08/2004CN1527820A 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders
09/08/2004CN1527809A Process for the preparation of 7-substituted 3-alkyl-3H-isobenzofuran-1-one derivatives
09/08/2004CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications
09/08/2004CN1526710A Prepn of 4-chlorophthalic anhydride
09/08/2004CN1526709A 3,4,5-trisubstituted-5-hydroxy-2(5hydro)-furaldone compound and its synthesis and use
09/08/2004CN1165531C Alpha-methylbenzyl-containing thioure a inhibitors of herpes viruses containing phenylenedimine group
09/08/2004CN1165508C Methyl oxirane dibenzoylressorinol UV absorbers
09/08/2004CN1165505C Method for selective hydrolysis of acetals or ketals compound in presence of 2-benzo [c] furanone
09/08/2004CN1165337C Synthetic cryptophycins
09/07/2004US6787671 Catalytic osmium-assisted oxidative cleavage of olefins
09/07/2004US6787570 Administering an aromatic or heteroaromatic substituted tertiaryamine compound to treat atherosclerosis, dyslipidemia, and other coronary artery diseases
09/07/2004US6787536 Hydroxamic acid derivatives
09/07/2004CA2105709C Substituted cyclohexane derivatives, processes for their preparation and the use of the compounds for treating diseases
09/02/2004WO2004074242A2 Halogenated oxime derivatives and the use thereof as latent acids
09/02/2004WO2004074236A1 Novel transcriptional factor, process for producing the same and use thereof
09/02/2004WO2004073709A1 Antimicrobial agents
09/02/2004WO2004073606A2 Sulfonamide derivatives as ppar modulators
09/02/2004WO2004041256A3 Safe chemical uncouplers for the treatment of obesity
09/02/2004WO2003049698A8 Substituted hydrazones as inhibitors of cyclooxygenase-2
09/02/2004US20040171894 Process for the catalytic oxidation of hydrocarbons
09/02/2004US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/02/2004US20040171866 Transistros; liquid crystals display; electrooptics
09/02/2004US20040171851 Process for the preparation of 5-carboxyphthalide
09/02/2004US20040171842 VIRICIDES; uSING A SECONDARY AMIDE COMPOUNDAIDS
09/02/2004US20040171833 Ligands for metals and improved metal-catalyzed processes based thereon
09/02/2004US20040171677 for combatting neuropathic pain.for the treatment of neurodegenerative diseases, preferably of Alzheimer's disease, Parkinson's disease or Huntington's chorea, migraine, stroke, cerebral ischaemia, cerebral infarct, cerebral edema, schizophrenia
09/02/2004US20040171662 Biaryl-type compounds, CD color fixing agent and method for determination of absolute configuration
09/02/2004US20040171653 HIV, AIDS; such as 2-[[(dimethylamino)acetyl]amino]-N-[3-[[[(2-hydroxy-1,1-dimethylethyl)amino]sulfonyl](3-methylbutyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-3,3-dimethylbutanamide
09/02/2004US20040171612 Novel compounds with analgesic effect
09/02/2004US20040171491 Substituted benzoylcyclohexenones and their use as herbicidal agents
09/02/2004US20040171490 Preventing infestation of plants by phytopathogenic microorganisms; horticulture, agriculture
09/02/2004CA2512883A1 Sulfonamide derivatives as ppar modulators
09/02/2004CA2511979A1 Halogenated oxime derivatives and the use thereof as latent acids
09/01/2004EP1452524A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses"
09/01/2004EP1452522A2 Novel compounds and compositions as protease inhibitors
09/01/2004EP1452521A1 Cyclic compound and ppar agonist
09/01/2004EP1451195A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
09/01/2004EP1451169A1 Novel compounds for the treatment of cardiac arrhythmia, synthesis, and methods of use
09/01/2004EP1451148A2 2,w-diaminocarboxylic acid compounds
09/01/2004EP1451133A2 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
09/01/2004EP1383755B1 Separation of 2,5-dihydrofuran and water from mixtures thereof by extractive distillation
09/01/2004EP1242410B1 Novel compounds
09/01/2004EP1183261B1 Method for separating analogous organic compounds
09/01/2004CN1525978A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
09/01/2004CN1525959A Muller Klaus-helmut